The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.
about
COPD and its comorbidities: Impact, measurement and mechanismsPalliative and end-of-life care conversations in COPD: a systematic literature reviewPulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary careGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation studyThe Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseMulti-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics.Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care.Change in health status in COPD: a seven-year follow-up cohort study.Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.Management of COPD exacerbations in primary care: a clinical cohort study.Prediction and prevention of exacerbations and mortality in patients with COPD.Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study.Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot studyMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma.National cohort data from Sweden to the National COPD audit in England and Wales: grand designs for quality improvement.Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014.Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD.Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.Demographic, health behavioral, and self-management abilities associated with disease severity among patients with chronic obstructive pulmonary disease: An exploratory study.Ethnic Inequalities in COPD Outcomes: a Register-Based Study in Copenhagen, Denmark.Fatigue Affects Health Status and Predicts Mortality Among Subjects with COPD: Report from the Population-Based OLIN COPD Study.Comparison of Multiple Chronic Obstructive Pulmonary Disease (COPD) Indices in Chinese COPD Patients.Assessment of COPD in primary care: new evidence supports use of the DOSE indexImproving prediction of risk of hospital admission in chronic obstructive pulmonary disease: application of machine learning to telemonitoring data (Preprint)
P2860
Q26786812-29C2DDA8-AA40-41DA-8E5D-4DD5E98C1954Q33609949-C1B67AD0-8550-437F-B654-E1723E9A6E18Q33806754-E70860C5-2AFE-4599-A00B-1A81A5B76ACFQ34550471-791F8152-EC0D-41B2-BC8F-3EA2CB127C13Q35112110-11B4F28C-6D77-491A-81D2-71870FEFF1D7Q35695038-3584ED23-77CB-4670-8A3D-53205EC58A27Q35981939-B84041E9-99B7-4794-B944-E9F3597A2F91Q36190129-2DD4516E-A2C6-4C0B-84EB-3548AB01D4DAQ36908069-839E4A51-2719-4E2F-A0C1-5885807E36DCQ36945936-A6186E87-AE82-4EEB-A5D0-C18A86D8E5DAQ37350573-E2CDFDD8-7403-48F9-BB0B-1536AB645FB7Q37353892-FE8C10E8-6117-418D-941E-3D5674E2EC70Q37676225-14FB4837-0726-4801-AED5-CE2A78C6A6EEQ38151518-C351E0DF-AE08-4C2D-9BD5-28BE934BBBB5Q38823010-8F998E69-EB93-412A-B22E-70E2A96DC3A8Q39443495-172474C7-EBE3-4057-9A6D-E969B51916AEQ42370604-897BE99F-A4EF-43A6-9A1A-35D6C3813362Q43522149-41A9599E-1844-4088-9321-A2098F386B49Q44779253-C6D4D866-19A4-46C6-AEF1-127384B5495BQ47108680-A769A6E1-9F40-40CF-96A7-65C86EABFB12Q47646532-796967E5-327C-43BA-8833-DB01B98CA1CEQ47646743-03550C78-83C6-46D4-A93F-291F3599883CQ47984024-545BCCBA-A0E6-4C0E-B1B1-5C4AA90682A6Q48005348-7F4D8AE1-5877-4C6D-9167-1C28641FC14FQ50108161-3B32DBD3-1100-4FDA-B705-5302D558114DQ50635241-EE007160-E31E-4913-B459-A6CF43E923AAQ55048667-A01AE28F-5177-4893-8AFC-11433ABD2090Q57697652-3FB5F91C-57E9-4E4E-9518-65470B22AE82Q57850927-778D19B6-B121-4CDF-952D-889792B3DF67
P2860
The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The Dyspnoea, Obstruction, Smo ...... edictive of mortality in COPD.
@en
type
label
The Dyspnoea, Obstruction, Smo ...... edictive of mortality in COPD.
@en
prefLabel
The Dyspnoea, Obstruction, Smo ...... edictive of mortality in COPD.
@en
P2093
P2860
P356
P1476
The Dyspnoea, Obstruction, Smo ...... redictive of mortality in COPD
@en
P2093
Björn Ställberg
Christer Janson
Josefin Sundh
Karin Lisspers
P2860
P2888
P304
P356
10.4104/PCRJ.2012.00054
P577
2012-09-01T00:00:00Z
P5875
P6179
1027041414